ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank64
3Y CAGR-31.9%
5Y CAGR-12.0%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-31.9%/yr
Annual compound
5Y CAGR
-12.0%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive declineFair Value
PeriodValueYoY Change
20250.03-23.8%
20240.04-42.7%
20230.08-27.6%
20220.11+14.6%
20210.09+45.4%
20200.06+406.2%
20190.01-
20180.00-
20170.00-
20160.00-